AKR1C3 and hepatocellular carcinoma: Interestingly, Wu et al. reported that AKR1C3 resulted in a higher ECAR/OCR ratio, suggesting that AKR1C3 could drive a metabolic shift from oxidative phosphorylation to glycolysis in HCC cells [16].